Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an attractive novel therapeutic option for the treatment of type 2 diabetes. They block the reabsorption of filtered glucose in kidneys, mainly in proximal renal tubules, resulting in increased urinary glucose excretion and correction of the dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Peralta, Fernando, Abreu, Cristina, Lecube, Albert, Bellido, Diego, Soto, Alfonso, Morales, Cristóbal, Brito-Sanfiel, Miguel, Umpierrez, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Practical Approach/CME Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630545/
https://www.ncbi.nlm.nih.gov/pubmed/28721687
http://dx.doi.org/10.1007/s13300-017-0277-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630545/
https://www.ncbi.nlm.nih.gov/pubmed/28721687
http://dx.doi.org/10.1007/s13300-017-0277-0

Ejemplares similares